Sickle cell patients are characterized by a reduced glycocalyx volume

EJ van Beers, M Nieuwdrop, AJ Duits, LM Evers, John-john Schnog, BJ Biemond

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
5 Downloads (Pure)


The glycocalyx is an important anti-inflammatory and anti-adhesive barrier at the luminal side of endothelial cells. Glycocalyx volume was significantly reduced in sickle cell patients (HbSS/HbS beta(0)-thalassemia median 0.47L, IQR 0.27-0.66, HbSC/HbS beta(+)-thalassemia 0.23L, 0.0-0.58) compared with controls (1x10(9)L, 0.52-1.77) (p=0.03). Reduced glycocalyx may be a new factor in the pathophysiology of sickle cell disease.
Original languageUndefined/Unknown
Pages (from-to)307-308
Number of pages2
Issue number2
Publication statusPublished - 2008

Research programs

  • EMC MM-02-41-04

Cite this